These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 19633967

  • 1. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
    Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R, Zivadinov R.
    J Neurol; 2010 Jan; 257(1):63-71. PubMed ID: 19633967
    [Abstract] [Full Text] [Related]

  • 2. Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
    Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A, Weinstock-Guttman B.
    Neurol Res; 2012 Oct; 34(8):761-9. PubMed ID: 22971466
    [Abstract] [Full Text] [Related]

  • 3. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE, Zivadinov R.
    Neuroimage; 2007 Jul 01; 36(3):746-54. PubMed ID: 17498974
    [Abstract] [Full Text] [Related]

  • 4. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A, Dehmeshki J, Peters KR, Griffin CM, Brex PA, Silver N, Ciccarrelli O, Chard DT, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2003 Dec 01; 9(6):566-73. PubMed ID: 14664468
    [Abstract] [Full Text] [Related]

  • 5. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
    Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, Hussein S, Conger A, Calabresi P, Balcer LJ, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):96-105. PubMed ID: 19439327
    [Abstract] [Full Text] [Related]

  • 6. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Jul 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 7. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.
    Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E, Dwyer MG, Zivadinov R.
    Mult Scler; 2020 Mar 15; 26(3):322-332. PubMed ID: 30755085
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 15; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 11. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
    Fisniku LK, Altmann DR, Cercignani M, Tozer DJ, Chard DT, Jackson JS, Miszkiel KA, Schmierer K, Thompson AJ, Miller DH.
    Mult Scler; 2009 Jun 15; 15(6):668-77. PubMed ID: 19435751
    [Abstract] [Full Text] [Related]

  • 12. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis.
    Ge Y, Grossman RI, Udupa JK, Babb JS, Mannon LJ, McGowan JC.
    J Comput Assist Tomogr; 2002 Jun 15; 26(1):62-8. PubMed ID: 11801905
    [Abstract] [Full Text] [Related]

  • 13. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S, Enzinger C, Ropele S, Wallner M, Fazekas F.
    Mult Scler; 2008 Mar 15; 14(2):205-11. PubMed ID: 17986507
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, Chard DT.
    Mult Scler; 2016 Feb 15; 22(2):150-9. PubMed ID: 26014608
    [Abstract] [Full Text] [Related]

  • 15. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, Ourselin S, Miller DH, Chard DT.
    Mult Scler; 2014 Sep 15; 20(10):1322-30. PubMed ID: 24552746
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regional specificity of magnetization transfer imaging in multiple sclerosis.
    Tjoa CW, Benedict RH, Dwyer MG, Carone DA, Zivadinov R.
    J Neuroimaging; 2008 Apr 15; 18(2):130-6. PubMed ID: 18315593
    [Abstract] [Full Text] [Related]

  • 18. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.
    Inglese M, Madelin G, Oesingmann N, Babb JS, Wu W, Stoeckel B, Herbert J, Johnson G.
    Brain; 2010 Mar 15; 133(Pt 3):847-57. PubMed ID: 20110245
    [Abstract] [Full Text] [Related]

  • 19. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.
    Mult Scler; 2007 May 15; 13(4):490-501. PubMed ID: 17463072
    [Abstract] [Full Text] [Related]

  • 20. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mesaros S, Rocca M, Sormani M, Valsasina P, Markowitz C, De Stefano N, Montalban X, Barkhof F, Ranjeva J, Sailer M, Kappos L, Comi G, Filippi M.
    Mult Scler; 2010 Mar 15; 16(3):325-31. PubMed ID: 20086023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.